Cargando…

Proteasome activator PA200 regulates myofibroblast differentiation

The proteasome is essential for the selective degradation of most cellular proteins and is fine-tuned according to cellular needs. Proteasome activators serve as building blocks to adjust protein turnover in cell growth and differentiation. Understanding the cellular function of proteasome activatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Welk, Vanessa, Meul, Thomas, Lukas, Christina, Kammerl, Ilona E., Mulay, Shrikant R., Schamberger, Andrea C., Semren, Nora, Fernandez, Isis E., Anders, Hans-Joachim, Günther, Andreas, Behr, Jürgen, Eickelberg, Oliver, Korfei, Martina, Meiners, Silke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6811633/ https://www.ncbi.nlm.nih.gov/pubmed/31645612 http://dx.doi.org/10.1038/s41598-019-51665-0

Ejemplares similares

In-gel proteasome assay to determine the activity, amount, and composition of proteasome complexes from mammalian cells or tissues
por: Yazgili, Ayse Seda, et al.
Publicado: (2021)

Validation of the 2(nd) Generation Proteasome Inhibitor Oprozomib for Local Therapy of Pulmonary Fibrosis
por: Semren, Nora, et al.
Publicado: (2015)

The Proteasome Activator PA200/PSME4: An Emerging New Player in Health and Disease
por: Yazgili, Ayse Seda, et al.
Publicado: (2022)

Metformin Induces Resistance of Cancer Cells to the Proteasome Inhibitor Bortezomib
por: Schlesser, Camille, et al.
Publicado: (2022)

A Lysine Residue at the C-Terminus of MHC Class I Ligands Correlates with Low C-Terminal Proteasomal Cleavage Probability
por: Schmalen, Adrian, et al.
Publicado: (2023)

The Proteasome Activators Blm10/PA200 Enhance the Proteasomal Degradation of N-Terminal Huntingtin
por: Aladdin, Azzam, et al.
Publicado: (2020)

Cryo-EM structures of the human PA200 and PA200-20S complex reveal regulation of proteasome gate opening and two PA200 apertures
por: Guan, Hongxin, et al.
Publicado: (2020)

Proteasome function is not impaired in healthy aging of the lung
por: Caniard, Anne, et al.
Publicado: (2015)

DNA sensing via the cGAS/STING pathway activates the immunoproteasome and adaptive T‐cell immunity
por: Wang, Xinyuan, et al.
Publicado: (2023)

Activation of immune cell proteasomes in peripheral blood of smokers and COPD patients: implications for therapy
por: Kammerl, Ilona E., et al.
Publicado: (2022)

Proteasome activators, PA28γ and PA200, play indispensable roles in male fertility
por: Huang, Lin, et al.
Publicado: (2016)

The role of proteasome activators PA28αβ and PA200 in brown adipocyte differentiation and function
por: Koçberber, Zeynep, et al.
Publicado: (2023)

Proteasome-Associated Proteins, PA200 and ECPAS, Are Essential for Murine Spermatogenesis
por: Sato, Ban, et al.
Publicado: (2023)

Characterization of Fully Recombinant Human 20S and 20S-PA200 Proteasome Complexes
por: Toste Rêgo, Ana, et al.
Publicado: (2019)

Proteasome activator PA200 maintains stability of histone marks during transcription and aging
por: Jiang, Tian-Xia, et al.
Publicado: (2021)

Next-generation personalized drug discovery: the tripeptide GHK hits center stage in chronic obstructive pulmonary disease
por: Meiners, Silke, et al.
Publicado: (2012)

DNA damage‐induced replication stress results in PA200‐proteasome‐mediated degradation of acetylated histones
por: Mandemaker, Imke K, et al.
Publicado: (2018)

The ageing lung under stress
por: Korfei, Martina, et al.
Publicado: (2020)

Blood Immunoproteasome Activity Is Regulated by Sex, Age and in Chronic Inflammatory Diseases: A First Population-Based Study
por: Kammerl, Ilona Elisabeth, et al.
Publicado: (2021)

Immunoproteasome dysfunction augments alternative polarization of alveolar macrophages
por: Chen, S, et al.
Publicado: (2016)

The proteasome activator PA200 regulates expression of genes involved in cell survival upon selective mitochondrial inhibition in neuroblastoma cells
por: Douida, Abdennour, et al.
Publicado: (2020)

PA28αβ: The Enigmatic Magic Ring of the Proteasome?
por: Cascio, Paolo
Publicado: (2014)

Structure, Function, and Allosteric Regulation of the 20S Proteasome by the 11S/PA28 Family of Proteasome Activators
por: Thomas, Taylor, et al.
Publicado: (2023)

PA28γ: New Insights on an Ancient Proteasome Activator
por: Cascio, Paolo
Publicado: (2021)

Downregulation of PA28α induces proteasome remodeling and results in resistance to proteasome inhibitors in multiple myeloma
por: Gu, Yanyan, et al.
Publicado: (2020)

Limbal, low-grade myofibroblastic sarcoma: Case report and literature review
por: Mulay, Kaustubh, et al.
Publicado: (2020)

P803: CRIP1 INDUCES PIS RESISTANCE BY FORMING A COMPLEX WITH USP7/PA200 AND ENHANCING PROTEASOME ACTIVITY AND AUTOPHAGY IN MULTIPLE MYELOMA
por: Yu, Zhen, et al.
Publicado: (2023)

Proteasome Activators, PA28α and PA28β, Govern Development of Microvascular Injury in Diabetic Nephropathy and Retinopathy
por: Yadranji Aghdam, Saeed, et al.
Publicado: (2016)

Inclusive photon production in pA and AA collisions at 200 GeV/u
por: Åkesson, T, et al.
Publicado: (1989)

Proteasome activator 28γ (PA28γ) allosterically activates trypsin-like proteolysis by binding to the α-ring of the 20S proteasome
por: Thomas, Taylor A., et al.
Publicado: (2022)

MiR-200c Regulates Noxa Expression and Sensitivity to Proteasomal Inhibitors
por: Lerner, Mikael, et al.
Publicado: (2012)

Cryo-EM of mammalian PA28αβ-iCP immunoproteasome reveals a distinct mechanism of proteasome activation by PA28αβ
por: Chen, Jinhuan, et al.
Publicado: (2021)

Detection and quantification of epithelial progenitor cell populations in human healthy and IPF lungs
por: Smirnova, N. F., et al.
Publicado: (2016)

Regulation of Immunoproteasome Function in the Lung
por: Keller, Ilona E., et al.
Publicado: (2015)

Systems medicine advances in interstitial lung disease
por: Greiffo, Flavia R., et al.
Publicado: (2017)

Editorial: Negative Regulators of Innate Immunity and Their Role in Host Responses to Injury and Infection
por: Mulay, Shrikant R., et al.
Publicado: (2022)

Differential Influence on Cytotoxic T Lymphocyte Epitope Presentation by Controlled Expression of Either Proteasome Immunosubunits or Pa28
por: van Hall, Thorbald, et al.
Publicado: (2000)

Removal of damaged proteins during ES cell fate specification requires the proteasome activator PA28
por: Hernebring, Malin, et al.
Publicado: (2013)

PaCS Is a Novel Cytoplasmic Structure Containing Functional Proteasome and Inducible by Cytokines/Trophic Factors
por: Sommi, Patrizia, et al.
Publicado: (2013)

Proteasome activator PA28γ-dependent degradation of coronavirus disease (COVID-19) nucleocapsid protein
por: Zhang, Haiyang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_56mc468hg2vhcl5llgjrkssrj9